Milford Molecular Diagnostics

Milford Molecular Diagnostics is a Connecticut-based clinical molecular diagnostics laboratory focused on DNA sequencing-based infectious disease and women’s health testing. The company appears to operate as a high-complexity CLIA-certified laboratory offering clinician-ordered and in some cases direct-access diagnostic services, with particular emphasis on Lyme disease testing using PCR amplification plus Sanger sequencing confirmation. Public materials also describe testing capabilities for HPV, SARS-CoV-2 variant identification, and selected sexually transmitted and viral pathogens. Rather than developing therapeutics, the company’s business is laboratory-developed diagnostics and related clinical testing services. The organization is closely associated with pathologist Dr. Sin Hang Lee, who is publicly identified as its director and as a developer of several sequencing-based assays.